tradingkey.logo

P3 Health Partners Inc

PIII
2.150USD
+0.240+12.57%
Cierre 02/06, 16:00ETCotizaciones retrasadas 15 min
7.03MCap. mercado
PérdidaP/E TTM

P3 Health Partners Inc

2.150
+0.240+12.57%

Más Datos de P3 Health Partners Inc Compañía

P3 Health Partners Inc. is a patient-centered and physician-led population health management company. The Company supports primary care providers with value-based care coordination and administrative services that improve patient outcomes and lower costs. Through partnerships with these local providers, it creates an enhanced patient experience by navigating, coordinating, and integrating the patient’s care within the healthcare system. Its technology platform, P3 Technology/Health Hub, enables physicians, care teams, patients and their family members to engage in the care journey. P3 Technology/Health Hub integrates clinical and claims data from disparate data points each month from payors, outpatient and inpatient facilities and other ancillary care settings. It has a network of more than 3,100 affiliated primary care providers across the country. Its local teams of healthcare professionals manage the care of thousands of patients in 27 counties across five states.

Información de P3 Health Partners Inc

Símbolo de cotizaciónPIII
Nombre de la empresaP3 Health Partners Inc
Fecha de salida a bolsaFeb 10, 2021
Director ejecutivoCoffman (Aric)
Número de empleados360
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 10
Dirección2045 W Grand Ave Ste B
CiudadCHICAGO
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal60612-1577
Teléfono13128228897
Sitio Webhttps://ir.p3hp.org/
Símbolo de cotizaciónPIII
Fecha de salida a bolsaFeb 10, 2021
Director ejecutivoCoffman (Aric)

Ejecutivos de P3 Health Partners Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Amir Bacchus, M.D.
Dr. Amir Bacchus, M.D.
Co-Founder, Chief Medical Officer, Director
Co-Founder, Chief Medical Officer, Director
45.13K
--
Mr. Gregory D. (Greg) Wasson
Mr. Gregory D. (Greg) Wasson
Independent Director
Independent Director
21.36K
+2000.00%
Mr. Mark Alan Thierer
Mr. Mark Alan Thierer
Independent Chairman of the Board
Independent Chairman of the Board
16.85K
+4000.00%
Ms. Mary A. Tolan
Ms. Mary A. Tolan
Independent Director
Independent Director
4.17K
+2000.00%
Mr. Gregory N. (Greg) Kazarian
Mr. Gregory N. (Greg) Kazarian
Director
Director
4.17K
+2000.00%
Mr. Jeffrey Gary (Jeff) Park
Mr. Jeffrey Gary (Jeff) Park
Independent Director
Independent Director
4.17K
+2000.00%
Mr. Lawrence B. (Larry) Leisure
Mr. Lawrence B. (Larry) Leisure
Independent Director
Independent Director
--
--
Dr. Thomas E. (Tom) Price, M.D.
Dr. Thomas E. (Tom) Price, M.D.
Independent Director
Independent Director
--
--
Dr. Aric Coffman, M.D.
Dr. Aric Coffman, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Ryan Halstead
Mr. Ryan Halstead
Managing Director
Managing Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Amir Bacchus, M.D.
Dr. Amir Bacchus, M.D.
Co-Founder, Chief Medical Officer, Director
Co-Founder, Chief Medical Officer, Director
45.13K
--
Mr. Gregory D. (Greg) Wasson
Mr. Gregory D. (Greg) Wasson
Independent Director
Independent Director
21.36K
+2000.00%
Mr. Mark Alan Thierer
Mr. Mark Alan Thierer
Independent Chairman of the Board
Independent Chairman of the Board
16.85K
+4000.00%
Ms. Mary A. Tolan
Ms. Mary A. Tolan
Independent Director
Independent Director
4.17K
+2000.00%
Mr. Gregory N. (Greg) Kazarian
Mr. Gregory N. (Greg) Kazarian
Director
Director
4.17K
+2000.00%
Mr. Jeffrey Gary (Jeff) Park
Mr. Jeffrey Gary (Jeff) Park
Independent Director
Independent Director
4.17K
+2000.00%

Desglose de ingresos

FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
La empresa aún no ha revelado los datos relevantes.
Por regiónUSD
Nombre
Ganancia
Proporción
United States
345.25M
0.00%
Por negocio
Por región
La empresa aún no ha revelado los datos relevantes.

Estadísticas de accionistas

Actualizado: vie., 22 de ago
Actualizado: vie., 22 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Chicago Pacific Founders UGP LLC
46.97%
Leavitt Equity Partners II LP
10.84%
Alyeska Investment Group, L.P.
5.50%
The Vanguard Group, Inc.
1.46%
Bacchus (Amir)
1.37%
Otro
33.85%
Accionistas
Accionistas
Proporción
Chicago Pacific Founders UGP LLC
46.97%
Leavitt Equity Partners II LP
10.84%
Alyeska Investment Group, L.P.
5.50%
The Vanguard Group, Inc.
1.46%
Bacchus (Amir)
1.37%
Otro
33.85%
Tipos de accionistas
Accionistas
Proporción
Corporation
57.81%
Hedge Fund
5.50%
Individual Investor
4.27%
Investment Advisor
3.59%
Investment Advisor/Hedge Fund
1.78%
Research Firm
0.10%
Otro
26.94%

Participación institucional

Actualizado: jue., 1 de ene
Actualizado: jue., 1 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
132
360.78K
10.98%
-427.31K
2025Q3
140
358.16K
10.96%
-476.81K
2025Q2
159
2.39M
73.22%
-351.07K
2025Q1
163
2.40M
73.55%
-322.33K
2024Q4
164
121.70M
75.84%
-21.19M
2024Q3
165
70.21M
46.23%
-6.58M
2024Q2
165
74.96M
49.19%
+19.75M
2024Q1
158
50.37M
43.55%
+5.90M
2023Q4
154
52.28M
45.78%
+2.36M
2023Q3
212
65.33M
71.01%
-13.71M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Chicago Pacific Founders UGP LLC
1.54M
46.97%
--
--
Jun 04, 2025
Leavitt Equity Partners II LP
356.27K
10.84%
+159.49K
+81.05%
May 24, 2024
Alyeska Investment Group, L.P.
180.91K
5.5%
--
--
Sep 30, 2025
The Vanguard Group, Inc.
48.72K
1.48%
+10.36K
+27.00%
Sep 30, 2025
Bacchus (Amir)
45.13K
1.37%
--
--
Apr 09, 2025
Corient Private Wealth LLC
35.37K
1.08%
--
--
Sep 30, 2025
Abdou (Sherif)
32.16K
0.98%
--
--
Apr 09, 2025
Trinity Financial Advisors LLC
26.68K
0.81%
+1.18K
+4.62%
Sep 30, 2025
EMFO, LLC
28.55K
0.87%
+8.13K
+39.80%
Jun 30, 2024
Wasson (Gregory D)
21.36K
0.65%
+2.00K
+10.33%
Aug 06, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
ProShares UltraPro Russell2000
0%
ProShares Hedge Replication ETF
0%
Global X Russell 2000 ETF
0%
Global X Russell 2000 Covered Call ETF
0%
Proshares Ultra Russell 2000
0%
iShares Micro-Cap ETF
0%
Fidelity Nasdaq Composite Index ETF
0%
iShares Russell 2000 Growth ETF
0%
iShares Russell 2000 ETF
0%
ProShares UltraPro Russell2000
Proporción0%
ProShares Hedge Replication ETF
Proporción0%
Global X Russell 2000 ETF
Proporción0%
Global X Russell 2000 Covered Call ETF
Proporción0%
Proshares Ultra Russell 2000
Proporción0%
iShares Micro-Cap ETF
Proporción0%
Fidelity Nasdaq Composite Index ETF
Proporción0%
iShares Russell 2000 Growth ETF
Proporción0%
iShares Russell 2000 ETF
Proporción0%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Apr 04, 2025
Merger
50→1
Fecha
Fecha ex-dividendo
Tipo
Relación
Apr 04, 2025
Merger
50→1
KeyAI